Pompe Disease Market in the US, Scope, Analysis and Forecasts to 2019
ReportsWeb.com published “Pompe Disease Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, October 17, 2017 ) Pompe disease, a type of LSD, is caused by mutations in the GAA gene. These mutations inhibit the mechanism of action of GAA, an enzyme responsible for catabolizing glycogen, resulting in accumulation of glycogen in the lysosomes of the cells. The buildup of glycogen in certain organs and tissues, especially in the muscles, hinders the normal functions of the organs. Pompe disease can be further classified as infantile-onset and adult-onset Pompe disease. As the disease is an autosomal recessive hereditary disorder, both parents are carriers and can pass one copy of the mutated gene to their offspring. The disease affects both men and women.
Publisher's analysts forecast the pompe disease market in the US to grow at a CAGR of 10.68 % over the period 2014-2019.
For more information http://www.reportsweb.com/pompe-disease-market-in-the-us-2015-2019
Covered in this report
This report covers the present scenario and the growth prospects of the pompe disease market in US for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of the drugs available in the US market and the drug candidates that are in various phases of development for the treatment of Pompe disease.
The report also presents the vendor landscape and a corresponding detailed analysis of the major vendors in the market. In addition, it discusses the major drivers that influence the growth and the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.
Publisher's report, Pompe Disease Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the landscape of the market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key vendors
- Amicus Therapeutics
- BioMarin Pharmaceutical
- Genzyme
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001202072/sample
Other prominent vendors
- Audentes Therapeutics
- EpiVax
- Oxyrane
- Sangamo BioSciences
- Valerion Therapeutics
Market driver
- Special provision for orphan drugs
- For a full, detailed list, view our report
Market challenge
- Limited patient population
- For a full, detailed list, view our report
Market trend
- Growing public awareness
- For a full, detailed list, view our report
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202072/buying
Publisher's analysts forecast the pompe disease market in the US to grow at a CAGR of 10.68 % over the period 2014-2019.
For more information http://www.reportsweb.com/pompe-disease-market-in-the-us-2015-2019
Covered in this report
This report covers the present scenario and the growth prospects of the pompe disease market in US for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of the drugs available in the US market and the drug candidates that are in various phases of development for the treatment of Pompe disease.
The report also presents the vendor landscape and a corresponding detailed analysis of the major vendors in the market. In addition, it discusses the major drivers that influence the growth and the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.
Publisher's report, Pompe Disease Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the landscape of the market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key vendors
- Amicus Therapeutics
- BioMarin Pharmaceutical
- Genzyme
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001202072/sample
Other prominent vendors
- Audentes Therapeutics
- EpiVax
- Oxyrane
- Sangamo BioSciences
- Valerion Therapeutics
Market driver
- Special provision for orphan drugs
- For a full, detailed list, view our report
Market challenge
- Limited patient population
- For a full, detailed list, view our report
Market trend
- Growing public awareness
- For a full, detailed list, view our report
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202072/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results